ArticleDiabetologia2007

Liver X receptor antagonist reduces lipid formation and increases glucose metabolism in myotubes from lean, obese and type 2 diabetic individuals.

E T Kase et al.PubMed ↗Publisher ↗

No numbers read from the abstract.